UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

CONTRAVIR PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

000-55020

 

46-2783806

(State or Other Jurisdiction of

 

(Commission File Number)

 

(IRS Employer

Incorporation or Organization)

 

 

 

Identification No.)

 

399 Thornall Street, First Floor
Edison, New Jersey 08837

(Address of principal executive offices) (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be registered:  Common Stock, par value $0.001 per share

 

Name of each exchange on which each class is to be registered:   The NASDAQ Stock Market LLC

 

If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

 

If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o

 

Securities Act registration statement file number to which this form relates: None

 

Securities to be registered pursuant to Section 12(g) of the Act: None .

 

 

 


 

Item 1.                                  Description of Registrant’s Securities to be Registered.

 

The description of the common stock of ContraVir Pharmaceuticals, Inc. (the “Registrant”), as included under the caption “Description of Capital Stock” in Exhibit 99.1 to Amendment No. 5 to Form 10 (Registration No. 000-55020 (the “Form 10”), filed under the Securities Exchange Act of 1934, as amended, is incorporated by reference herein.  In addition, any description of such securities contained in a form of prospectus relating to a registration statement subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

 

Item 2.                                  Exhibits.

 

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2


 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

CONTRAVIR PHARMACEUTICALS, INC.

 

 

 

 

Date:  February 23, 2015

By:

/s/ James Sapirstein

 

 

Name: James Sapirstein

 

 

Title:   Chief Executive Officer

 

3